EA201170138A1 - Соединения, используемые для профилактики или лечения аккомодационной астенопии - Google Patents

Соединения, используемые для профилактики или лечения аккомодационной астенопии

Info

Publication number
EA201170138A1
EA201170138A1 EA201170138A EA201170138A EA201170138A1 EA 201170138 A1 EA201170138 A1 EA 201170138A1 EA 201170138 A EA201170138 A EA 201170138A EA 201170138 A EA201170138 A EA 201170138A EA 201170138 A1 EA201170138 A1 EA 201170138A1
Authority
EA
Eurasian Patent Office
Prior art keywords
astenopia
prevention
treatment
accomodation
compounds used
Prior art date
Application number
EA201170138A
Other languages
English (en)
Inventor
Никола Пескосолидо
Алеардо Коверек
Original Assignee
Сигма-Тау Индустрие Фармасьютике Риуните С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. filed Critical Сигма-Тау Индустрие Фармасьютике Риуните С.П.А.
Publication of EA201170138A1 publication Critical patent/EA201170138A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Описано применение L-карнитина в сочетании с антиоксидантами, такими как витамин Е, и неорганическими элементами, такими как марганец/ цинк, натрий и калий, для получения физиологической добавки или лекарственного средства для применения в офтальмологии, для лечения или профилактики аккомодационной астенопии.
EA201170138A 2008-07-04 2009-06-25 Соединения, используемые для профилактики или лечения аккомодационной астенопии EA201170138A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08159676 2008-07-04
PCT/EP2009/057939 WO2010000661A1 (en) 2008-07-04 2009-06-25 Compounds useful for the prevention or treatment of accomodative asthenopia

Publications (1)

Publication Number Publication Date
EA201170138A1 true EA201170138A1 (ru) 2011-06-30

Family

ID=39968069

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170138A EA201170138A1 (ru) 2008-07-04 2009-06-25 Соединения, используемые для профилактики или лечения аккомодационной астенопии

Country Status (14)

Country Link
US (2) US20110268817A1 (ru)
EP (1) EP2303256A1 (ru)
JP (1) JP5555693B2 (ru)
KR (1) KR20110025824A (ru)
CN (2) CN102076336A (ru)
AR (1) AR072686A1 (ru)
AU (1) AU2009265841A1 (ru)
BR (1) BRPI0913909A2 (ru)
CA (1) CA2729708A1 (ru)
EA (1) EA201170138A1 (ru)
MX (1) MX2010013439A (ru)
SG (1) SG191700A1 (ru)
TW (1) TWI474817B (ru)
WO (1) WO2010000661A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180042978A1 (en) * 2008-04-10 2018-02-15 U.S. Nutraceuticals, Llc D/B/A Valensa International Method of treating photo-induced ocular fatigue and associated reduction in speed of ocular focus
CN110772604A (zh) * 2019-11-05 2020-02-11 何少明 一种护眼明目喷剂及其加工工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040058015A1 (en) * 2000-06-01 2004-03-25 Yuanjin Tao Compositions and methods for treating eye discomfort and eye disease
US7029712B1 (en) * 2002-07-17 2006-04-18 Biosyntrx Inc Treatment for dry eye syndrome
BRPI0612596A2 (pt) * 2005-07-01 2010-11-23 Sigma Tau Ind Farmaceuti uso de l-carnitina ou alcanoil-l-carnitinas para a preparação de um suplemento ou medicamento fisiológico para uso oftálmico na forma de gotas oftálmicas
WO2007006672A1 (en) * 2005-07-08 2007-01-18 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
EP2101725A1 (en) * 2006-12-14 2009-09-23 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Use of l-carnitine or of alkanoyl l-carnitines for the preparation of a physiological supplement or medicament for ophthalmic use in the form of eye drops
SG176525A1 (en) * 2006-12-22 2011-12-29 Sigma Tau Ind Farmaceuti Gel useful for the delivery of ophthalmic drugs

Also Published As

Publication number Publication date
WO2010000661A1 (en) 2010-01-07
SG191700A1 (en) 2013-07-31
TW201010694A (en) 2010-03-16
CN102076336A (zh) 2011-05-25
AU2009265841A1 (en) 2010-01-07
EP2303256A1 (en) 2011-04-06
US20110268817A1 (en) 2011-11-03
TWI474817B (zh) 2015-03-01
BRPI0913909A2 (pt) 2015-10-13
MX2010013439A (es) 2011-01-21
KR20110025824A (ko) 2011-03-11
AR072686A1 (es) 2010-09-15
US20140079809A1 (en) 2014-03-20
CA2729708A1 (en) 2010-01-07
CN104688718A (zh) 2015-06-10
JP2011526587A (ja) 2011-10-13
JP5555693B2 (ja) 2014-07-23

Similar Documents

Publication Publication Date Title
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
EA201291336A1 (ru) Замещенные 5-фтор-1н-пиразолопиридины и их применение
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA201290836A1 (ru) Связанные бис-арильные арилтриазолоны и их применение
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
CO6771409A2 (es) Acidos 1-bencilcicloalquilcarboxilicos sustituidos y su uso
EA201491605A1 (ru) Способы улучшения функции диафрагмы
CL2011002548A1 (es) Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica.
UY31765A (es) Dihidropirazolonas sustituidas y su uso
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
EA201390799A1 (ru) Триазолопиридины
EA201201239A1 (ru) Композиция, содержащая в качестве активного ингредиента l-карнитин в комбинации с гидроксикинуренин-о-бета-dl-глюкозидом, для предотвращения и/или лечения патологий глаза, вызванных ультрафиолетовым излучением
AR086395A1 (es) Envase para el tratamiento de patologias
UA107204C2 (uk) Протигрибкова композиція, що містить грибковий організм pythium oligandrum
NZ599265A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX2009011900A (es) Curacion de herida diabetica.
EA201200786A1 (ru) Комбинированная композиция, содержащая в качестве активного ингредиента l-карнитин или пропионил-l-карнитин, для предотвращения или лечения хронической венозной недостаточности
CL2009000919A1 (es) Uso de dronedarona o una sal farmaceuticamente aceptable para preparar un medicamento util en la prevencion y/o tratamiento de la hipocalemia.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
TR201004464A2 (tr) Kemik erimesi için formülasyon.
EA201390950A1 (ru) Гомогенные фармацевтические пероральные лекарственные формы, содержащие лерканидипин и эналаприл или их фармацетически приемлемые соли совместно с органической кислотой
MX2014001823A (es) Combinaciones de corroles y estatinas.
EA201170138A1 (ru) Соединения, используемые для профилактики или лечения аккомодационной астенопии